ASCO
Milestone Monday: A Win in China. A Shift in England. A Gap Nobody Named.
Three ASCO readouts, three announcements that claimed more than the data supported — and one question the conference floor has been too busy to ask.
Aakash Babu
Therapeutic
Therapeutic Thursday: The Field Is Sorting Itself. Watch Who Is Leaving and Why.
Cell and gene therapy has its first commercial products, its first profitable company, and its first wave of strategic exits. The exits are as informative as the deals.
Therapeutic
Therapeutic Thursday: The ADC Gold Rush Has a Crowding Problem
The clinical logic is sound, the deal volume is real, and the differentiation question is getting harder to ignore.
Monday
DND. Milestone Monday. The Noise Stops Here.
Week ahead: catalysts to watch 01 FDA leadership Agency calendar is light. The leadership question is not. Any movement on senior CDER appointments or the Commissioner's office affects review timelines and advisory committee scheduling for the rest of 2026. Ongoing 02 ASCO 2025: Chicago, May 30 to June